false 0001178253 0001178253 2022-09-28 2022-09-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): September 28, 2022

SCYNEXIS, Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

 

 

Delaware

 

001-36365

 

56-2181648

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

1 Evertrust Plaza, 13th Floor

Jersey City, New Jersey 07302-6548

(Address of Principal Executive Offices, and Zip Code)

(201)-884-5485

Registrant’s Telephone Number, Including Area Code

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.001

 

SCYX

 

Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 



 

Item 5.07. Submission of Matters to a Vote of Security Holders.

On September 28, 2022, SCYNEXIS, Inc. held its 2022 Special Meeting of Stockholders to approve the proposal to amend SCYNEXIS’s Amended and Restated Certificate of Incorporation, as amended, to increase the total number of authorized shares of common stock from 100,000,000 to 150,000,000 (the “Charter Amendment Proposal”) as described in detail in SCYNEXIS’s definitive proxy statement (the “Proxy Statement”) filed with the U.S. Securities and Exchange Commission on August 18, 2022.

The final voting results for the Charter Amendment Proposal submitted to a vote of stockholders at the Special Meeting, resulting in the approval of the Charter Amendment Proposal, are as follows:

 

For

 

Against

 

Abstain

 

Broker
Non-Votes

19,851,387

 

4,713,947

 

91,003

 

 

In connection with the Special Meeting, SCYNEXIS also solicited proxies with respect to a proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Charter Amendment Proposal (the “Adjournment Proposal”). Because there were sufficient votes represented at the time of the Special Meeting to approve the Charter Amendment Proposal, the Adjournment Proposal was moot and was not presented for approval by SCYNEXIS’s stockholders at the Special Meeting.

 

 

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

 

 

SCYNEXIS, Inc.

 

 

 

 

Date: September 29, 2022

 

 

 

By:

 

/s/ Marco Taglietti

 

 

 

 

Name:

 

Marco Taglietti, M.D.

 

 

 

 

Its:

 

Chief Executive Officer